Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    26-January-2001      
Issue 26 Next Update - 14:00 UTC 08:00 EST    27-January-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Proceed To Article In Today's Vidyya
Information for consumers on the Phylax AV Implantable Cardioverter Defibrillator is available in today's issue.

Proceed To Article Phylax AV Implantable Cardioverter Defibrillator System With Programmer Software
Two articles in today's issue contain information on cardiology devices that have been recently approved by the FDA. The first item, the Phylax AV Implantable Cardioverter Defibrillator (ICD) System with Programmer Software, is an implantable electronic device built inside a metal (titanium) shell that is placed under the skin in the shoulder area. The Phylax AV is used for patients who are at high risk of sudden death due to arrhythmia. More...

Proceed To Article New Device Information For Consumers: Navi-Star ® Diagnostic/Ablation Deflectable Tip Catheter
The recently approved, Navi-Star ® catheter is a steerable thin flexible catheter (tube) containing multiple electrodes. This catheter can provide information about the location of the electrophysiological conduction responsible for heart muscle contraction. More...

Proceed To Article Rats! The NTP Completes 500th Two-Year Rodent Study Which Is The Gold Standard of Animal Toxicology
The US National Toxicology Program published its 500th two-year safety test of chemicals in rodents — a landmark in a series that has influenced what is allowed in drugs, water, foods, and air, for these reports have often formed the foundation for regulatory action by the Food and Drug Administration, Environmental Protection Agency, Occupational Safety and Health Administration, and Consumer Product Safety Commission. More...

Proceed To Article Naphthalene Found To Cause Cancer In Famous Rat Study
Naphthalene, the chemical that gives mothballs that strong, familiar scent, showed clear evidence of causing cancer in male and female laboratory rats in a two-year study by the National Toxicology Program headquartered at the National Institute of Environmental Health Sciences in Research Triangle Park, N.C. The rats in the study were exposed by inhalation, just as most people are, in doses comparable to some human consumer and workplace exposures. More...

Proceed To Article

Lancet Study Confirms: Glucosamine Sulfate Reduces Progression of Osteoarthritis
Today's issue of The Lancet reports the results of a clinical trial that showed administration of the nutritional supplement, glucosamine sulfate, slows disease progression in patients with knee osteoarthritis. The three-year, double-blind, placebo-controlled study (Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Reginster J-Y, et al) was performed using 212 patients suffering from knee osteoarthritis who were randomly selected to receive 1500 mg once-a-day of oral glucosamine sulfate or a placebo for a three-year period. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 
Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.